Literature DB >> 8579035

Transcatheter closure of the patent ductus arteriosus: comparison between the Rashkind occluder device and the anterograde Gianturco coils technique.

O Galal1, M de Moor, F al-Fadley, Z M Hijazi.   

Abstract

Thirty-five patients (mean age 43.7 months, mean weight 13 kg) underwent anterograde patent ductus arteriosus (PDA) occlusion with Gianturco coils (coil group). These patients were compared with 35 age- and weight-matched patients who underwent closure of their PDA with the Rashkind umbrella device (device group). The mean PDA diameter at its narrowest point was 2.8 mm in the coil group and 2.7 mm in the device group. There was immediate closure angiographically in 20 (57%) of 35 in the coil group compared with 9 (26%) of 35 for the device group. Color flow mapping before discharge revealed complete closure in 30 (86%) of 35 in the coil group compared with 18 (51%) of 35 in the device group (chi square = 9.5455, p < 0.005). Mean fluoroscopy time was 18.5 minutes (median 13.5 minutes) and 14.7 minutes (median 13 minutes) for the coil and device, respectively. Four coils and one device embolized down the pulmonary artery; all were successfully retrieved in the catheterization lab. Coil closure of the small to moderate PDA is safe and effective. It is more effective in achieving immediate closure than the Rashkind device. More clinical trials with the coil technique are warranted to establish the long-term results of this technique.

Entities:  

Mesh:

Year:  1996        PMID: 8579035     DOI: 10.1016/s0002-8703(96)90368-3

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  2 in total

1.  Interventional pediatric cardiology: device closures.

Authors:  J L Wilkinson
Journal:  Indian J Pediatr       Date:  2000-07       Impact factor: 1.967

2.  Initial experience with the 3.3 Fr Mongoose® pigtail catheter for aortic angiography during patent ductus arteriosus closure in small patients.

Authors:  Zachary Hena; Nicole J Sutton; Gregory J Gates; Benjamin H Taragin; Robert H Pass
Journal:  Ann Pediatr Cardiol       Date:  2017 Sep-Dec
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.